Mr Peter Cheng

in-vivo molecular diagnosis

When needed Where needed

Mr Peter Cheng

Mr Peter Cheng is the Chief Technology Officer of Biobot Surgical Pte Ltd and Zicom Medtacc Pte Ltd. He is also a director in Zicom Medtacc Pte Ltd, a company focusing on investments and acceleration of early stage medical technologies companies. It is also supported by SPRING Singapore. Biobot Surgical Pte Ltd is a spinoff from SingHealth and NTU that has developed a robotic platform for performing transperineal prostate biopsy. Mr. Cheng graduated with a Bachelor in Mechanical Engineering Nanyang Technological Institute and bring along more than 25 years of R&D & management experience over a broad spectrum of industries; from digital storage to domestic appliances to wind energy.